Is Regeneron Pharmaceuticals, Inc. (REGN) Undervalued?
Based on the current stock price of $784.97 and a P/E ratio of 18.83,Regeneron Pharmaceuticals, Inc. has a PEG ratio of .
The Short Answer:
Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of , REGN appears to be fairly valued relative to its growth rate of -5.35%.
Based on a PEG ratio of 0.00.
Compare REGN vs Competitors
Use the calculator below to see how REGN stacks up against other stocks in the same industry.
How we analyzed REGN
We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 18.83and dividing it by the annual growth rate of -5.35%.
PEG = 18.83 (P/E) ÷ -5.35 (Growth) =
Frequently Asked Questions about REGN
What is the current PEG Ratio for Regeneron Pharmaceuticals, Inc. (REGN)?+
The current PEG Ratio for Regeneron Pharmaceuticals, Inc. is N/A. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.
Is REGN stock undervalued right now?+
Based on the PEG ratio of N/A, Regeneron Pharmaceuticals, Inc. appears to be fairly valued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.
What is the PEGY Ratio for REGN?+
The PEGY ratio for Regeneron Pharmaceuticals, Inc. is N/A. This metric accounts for dividend yield (0.45%), providing a more complete valuation picture.